Bonum Therapeutics
Zane Kraft is a seasoned scientist with extensive experience in immuno-oncology therapeutics. Currently employed at Bonum Therapeutics since September 2022, Zane previously held the position of Senior Associate Scientist at Good Therapeutics, Inc. from December 2018 to September 2022 and served as Senior Research Associate at OncoResponse Inc. from April 2016 to December 2018. Earlier in the career, Zane worked as an Associate Scientist at ZymoGenetics from October 2011 to April 2016 and began as a Research Technician III at Seattle Biomedical Research Institute from April 2003 to September 2011. Academic credentials include a Master's Degree in Microbiology and a Bachelor's Degree in Biology, both obtained from Central Washington University, with studies completed between 1995 and 2002.
Bonum Therapeutics
Bonum Therapeutics is creating a technology platform that can be used to treat a wide range of diseases, including cancer which is the company’s primary therapeutic area of focus—as well as metabolic diseases, immunology, and pain management.